There is an important association between eating fish and seafood with higher levels of mercury and being at a higher risk of developing amyotrophic lateral sclerosis (ALS), according to a preliminary study released this week.
In a briefing to the House Bipartisan Heroin Task Force, Geisel professor Lisa Marsch, PhD, Principal Investigator of the Northeast Node of the National Drug Abuse (NIDA) Clinical Trials Network, presented data from her NIDA-funded New Hampshire Hot Spot Study on heroin and synthetic drug use.
“We see this as a way to transform mental health treatment,” says Geisel’s William Hudenko.
Dartmouth researcher Ambrose Cheung, MD, has received a 2017 Harrington Scholar-Innovator Award, one of only a few given annually to top physician-scientists in the U.S. The award will support Cheung’s promising research to develop a vaccine or drug to combat MRSA—virulent staph bacteria causing infections that are increasingly resistant to antibiotics.
A new Dartmouth study shows that travel time is not a deterrent to radiation therapy for treatment of prostate cancer in New Hampshire.
Arminja Kettenbach, PhD, an assistant professor of Biochemistry and Cell Biology at Geisel, recently received two high-profile grant awards to support her research in proteomics, which is shedding new light on what goes wrong in cell division during cancer.
Surachai Supattapone, MD, PhD, a professor of biochemistry and cell biology at the Geisel School of Medicine, is among four Dartmouth professors named fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and the publisher of the journal Science.
Led by Alan I. Green, MD, a team of scientists at Dartmouth SYNERGY Clinical and Translational Science Institute and Geisel’s department of Biomedical Data Science are helping to lead a national effort to centralize IRB (institutional review board) review for clinical research among the NIH’s 64 CTSA research centers.
Research published in the journal Nature Communications describes distribution of a DNA defect in the glioblastoma genome and its relationship with patient survival.
Three innovative research pilots, pairing Dartmouth investigators with community-based partners, are being funded by Dartmouth SYNERGY’s Community Engagement Research Core to address challenging health problems facing our communities.